Randomized trial of biofilm testing to select antibiotics for cystic fibrosis airway infection
Pediatric Pulmonology2010Vol. 46(2), pp. 184–192
Citations Over TimeTop 10% of 2010 papers
Samuel M. Moskowitz, Julia Emerson, Sharon McNamara, Richard D. Shell, David M. Orenstein, Daniel Rosenbluth, Marcia Katz, Richard C. Ahrens, Douglas B. Hornick, Patricia M. Joseph, Ronald L. Gibson, Moira L. Aitken, Wade W. Benton, Jane L. Burns
Abstract
In this pilot study, antibiotic regimens based on biofilm testing did not differ significantly from regimens based on conventional testing in terms of microbiological and clinical responses. The predictive value of biofilm testing may nonetheless warrant evaluation in an adequately powered clinical trial in younger CF patients or those experiencing acute pulmonary exacerbation.
Related Papers
- → Stability of Meropenem After Reconstitution for Administration by Prolonged Infusion(2018)56 cited
- → Meropenem PK/PD Variability and Renal Function: “We Go Together”(2023)12 cited
- → Testing the mutant selection window hypothesis with meropenem: In vitro model study with OXA-48-producing Klebsiella pneumoniae(2023)10 cited
- → Comparison of antibiotic susceptibility patterns in Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) with invasive Pseudomonas aeruginosa from non-CF patients(2012)13 cited
- → In-vitro studies of meropenem(1989)88 cited